Searched for
CIPREMI
Pharma companies cut remdesivir injection prices on govt intervention: NPPAMinister of State for Chemicals and Fertilisers Mansukh Mandaviya held meetings with drug manufacturers and other stakeholders on April 12 ...- Indian demand for COVID-19 drug remdesivir rising sharply: CiplaRemdesivir was developed by U.S. drugmaker Gilead Sciences Inc, which cut its 2020 revenue forecast last month, citing lower-than-expected ...
- Remdesivir makers told to ramp up production by the department of pharmaceuticalsDelhi’s state regulator has written to chemists' association also about illegal imports of Covid-related drugs remdesivir, favipiravir and ...
- Cipla rises 2% as drugmaker launches remdesivir generic at Rs 4,000 per vialPharmaceutical major Mylan NV said its generic version of remdesivir will be priced at Rs 4,800
- Cipla launches generic version of remdesivir at Rs 4,000 per vial"We are proud to commercially launch Cipremi today (on Wednesday); amongst the lowest priced globally, and aim to supply over 80,000 vials ...
- Cipla to price remdesivir version for COVID-19 under 5,000 rupeesIndian pharma major Cipla Ltd and Hetero Labs gained approval to sell generic versions of remdesivir in the country. Remdesivir, intravenou...
- Hetero, Cipla to supply generic Remdesivir to hospitals this weekThe recommended course for a Covid-19 patient under oxygen support is five vials. The approved therapy is for moderate to severe patients.
- Cipla soars 9% on launching generic version of Covid-19 drug remdesivirRemdesivir is the only USFDA approved Emergency Use Authorisation (EUA) treatment for adult and paediatric patients hospitalised with suspe...
- Cipla launches generic remdesivir for coronavirus patientsThe USFDA had issued an Emergency Use Authorization (EUA) to Gilead Sciences Inc for emergency use of remdesivir for the treatment of coron...
Load More
